TREATMENT DATA INDICATORS IN THE UNODC DATA COLLECTION SYSTEM
IMPORTANCE OF TDI EXPERIENCES IN EUROPE FOR UNODC
• EU WORK ON HARMONIZATION OF DATA COLLECTION SYSTEMS PROVIDES IMPORTANT GUIDANCE ON HOW TO WORK AT GLOBAL LEVEL.
• TREATMENT DATA ARE IN MANY COUNTRIES THE ONLY DATA COLLECTED AND IMPROVING THEM IS AN IMPORTANT ELEMENT OF BUILDING NATIONAL INFORMATION SYSTEM.
REPORTING ON DRUG DEMAND REDUCTION• Developing an information set to measure achievement in respect of the targets
detailed in the Political Declaration and the Demand Reduction Declaration• Goals for 2003: establishment of legal measures and programmes (reviewed
during the Ministerial Segment of the Commission on Narcotic Drugs in April 2003)
• Goals for 2008: to significantly reduce demand for illicit drugs.
ACTION PLAN ON DEMAND REDUCTION
Under the Action Plan UNODC has been given 3 specific tasks:–To facilitate sharing of good practice strategies and programmes–To provide assistance in developing DDR strategies in line with the Guiding principles of drug demand reduction –To provide assistance for the establishment of national data collection systems.
GUIDING PRINCIPLES OF UNDCP DATA COLLECTION STRATEGY
• Sensitivity to different information resources
• Based on agreed standards of good practice
• Comparability with other information sets
BIENNIAL REPORTS QUESTIONNAIRE (BRQ)on Demand Reduction Activities• Mandated follow-up instrument of the UNGASS process
• To enable Member States to report on the progress
achieved in meeting the UNGASS objectives for 2003 and
2008
• To monitor structures, methods of working, target
population, extent and coverage of programmes,
difficulties encountered
BIENNIAL REPORTS QUESTIONNAIRE (BRQ)on Demand Reduction Activities
• Extent of coverage (low /medium or high) and programme execution (gender sensitive and evaluated in the areas of treatment and rehabilitation:
• detoxification• substitution treatment (therapy) excluding short-term
detoxification • non-pharmacological treatment • social reintegration
ANNUAL REPORTS QUESTIONNAIRE (ARQ)on Drug Abuse
• To review the progress made in meeting the
challenges set out in the Political Declaration
adopted by the General Assembly
• To monitor and increase global understanding of
the extent and nature of drug abuse
ANNUAL REPORTS QUESTIONNAIRE (ARQ)
Quantitative estimates and expert opinions on:
• prevalence of drug abuse among general and youth population
• prevalence of drug abuse among the school (youth) population
• injecting drug abuse
• severe drug abuse
• new developments in prevalence and patterns of drug abuse
• drug-related morbidity (HIV, HBV, HCV)
• Drug-related mortality
• drug treatment
• data collection capacity
ANNUAL REPORTS QUESTIONNAIRE (ARQ)
• Annually distributed to all Member States
• Annual Reports Questionnaire, 2001:103
submissions, response rate 54 %
• Electronic completion and submission made
possible
ANNUAL REPORTS QUESTIONNAIRE (ARQ) TREATMENT DEMAND
• Summary Expert Opinions
– Have people received treatment yes/no by drugs
– Ranking drugs as primary cause of receiving treatment
– Trends in the past in number of people receiving treatment (large/some increase/decrease or stable)
ANNUAL REPORTS QUESTIONNAIRE (ARQ) TREATMENT DEMAND
• Quantitative Estimates
– Estimated number of people receiving treatment– Percentage of people receiving treatment for first time ever– Percentage of females– Mean age– Percentage of drug injectors– Definition of “people treated for drug problems”
No. of people receiving treatment for cannabis type in Asia
71
15
5
2
1698
217
1
0 200 400 600 800 1000 1200 1400 1600 1800
Indonesia
Korea (Republic of)
Macau
Mongolia
Philippines
Saudi Arabia
Tajikistan
Asia
No. of people receiving treatment for cannabis type in Europe
12953030
2392301
600728
1245250865
3443256184336
3489
0 2000 4000 6000 8000 10000 12000 14000
CroatiaFranceGreece
HungaryIcelandIreland
ItalyLatv ia
LiechtensteinLux embourgNetherlands
PolandSlov akiaSw eden
United Kingdom
Euro
pe
No. of people receiving treatment for cannabis type in the Americas
214
11
7
20
116
88
0 50 100 150 200 250
Argentina
Dominican Republic
Grenada
Haiti
Saint Vincent and the Grenadines
Trinidad Tobago
Amer
icas
Percentage of people receiving treatment for the first ever time among people in treament for cannabis type
9684
81
8071
6966
6156
4023
191414
9
84
0 10 20 30 40 50 60 70 80 90 100
SeychellesIndonesia
Greece
LatviaSlovakia
Netherlands
Ireland
Saudi ArabiaFrance
LiechtensteinHaiti
Saint Vincent and the Grenadines
Mauritius
MongoliaDominican Republic
Hungary
Grenada
Estimated mean age of people in treatment for cannabis type
Seychelles 23Dominican Republic 25Saint Kitts and Nevis 25Saint Vincent and the Grenadines 29Korea (Republic of) 31Saudi Arabia 28Croatia 16France 26Greece 21Ireland 22Liechtenstein 22Netherlands 28Slovakia 20Turkey 28
Estimated percentage of females among people in treatment for cannabis type
Mauritius 2Seychelles 8Saint Vincent and the Grenadines 5Trinidad Tobago 8Indonesia 4Macau 1Croatia 4France 18Greece 11Hungary 4Ireland 18Latvia 20Netherlands 19Poland 2Slovakia 18Turkey 8United Kingdom 18
Global Assessment Programme on Drug Abuse (GAP)
The Global Assessment Programme (GAP) on Drug Abuse has facilitated an understanding of and improved information on the global drug situation.
Lisbon consensus January 2000 agreement on a set of core Indicators•Prevalence and incidende general population•Prevalence and incidence youth population•High-risk drug abuse•Drug-related morbidity•Drug-related mortality
Global Assessment Programme on Drug Abuse (GAP)
At the national level the GAP has:
•conducted information, need and resource analyses to produce strategic action plans
•Supported the establishment of data collection focal points and expert networks
•Provided training and resources to meet key information needs
Global Assessment Programme (GAP)Through its regional activities:• GAP has supported regional information systems• Encouraged networking among countries • Provided opportunities for trainingAt the global level:• Dissemination of methodological developments and best
practices (toolkit with modules on information systems, school surveys, estimation techniques, data management and analysis)
• Improved reporting standards• Increased the quality and coverage of the global information base
Global Assessment Programme (GAP) next steps• Technical support to regional sub-programmes and
national epidemiological units • Further development and harmonization of indicators and
data collection methodologies• Regional network development and exchange of
information, experience and survey results among national epidemiological units in the region;
• Promotion of the use of existing training packages (“methodological toolkit”) developed under the GAP and provision of technical assistance for regional training;
Global Assessment Programme (GAP) next steps• Development of training packages and organization
of regional training programmes on: • ARQ data management and interpretation to support policy planning; • Qualitative research and focused assessment studies;• Ethical issues and principles for drug abuse epidemiology;• Treatment reporting (possible cooperation with EMCDDA and other
agencies);• Monitoring of injecting drug abuse and associated HIV-related factors
• Technical assistance to national focal points in collection of national and regional data on drug abuse